Mid Cap Healthcare
Stocks Ranked by
Market Capitalization
Mid Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 163 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $704B.
The largest by market cap are Henry Schein (HSIC) at $9.98B, Oscar Health (OSCR) at $9.82B and Avantor (AVTR) at $9.64B.
Among institutional investors, Definium Therapeutics (DFTX) drew the most net new fund positions in Q2 2026: 148 funds opened new positions, taking total fund holders up 114 (46%) quarter-over-quarter.
- Combined market cap: $704B across 163 stocks.
- Mid Cap: market cap between $2B and $10B.
- Largest constituent: Henry Schein (HSIC), $9.98B market cap.
- Most net new fund positions in Q2 2026: Definium Therapeutics (DFTX), +114 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.